|
(2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺
|
R281688-100mg
|
≥98%,≥99%(ee) |
268556-62-3 |
100mg
|
¥ 299.9
|
现货 |
|
0 |
阿拉丁 |
|
(1'R,2'R,3aS,3“aS,8aR,8”aR)-(+)-3,3“,3a,3”a,8,8“,8a,8”a-八氢双螺{2H-茚并[1,2-d]噁唑-2,1'-环己烷-2',2“-[2H]茚并[1,2-d]噁唑}
|
R281494-50mg
|
≥97% |
947515-50-6 |
50mg
|
¥ 439.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
RS 102895盐酸盐
|
R274707-5mg
|
≥98% |
1173022-16-6 |
5mg
|
¥ 539.9
|
现货 |
|
0 |
阿拉丁 |
|
RS 102895盐酸盐
|
R274707-25mg
|
≥98% |
1173022-16-6 |
25mg
|
¥ 1699.9
|
现货 |
|
0 |
阿拉丁 |
|
RS 102895盐酸盐
|
R274707-100mg
|
≥98% |
1173022-16-6 |
100mg
|
¥ 3999.9
|
现货 |
|
0 |
阿拉丁 |
|
Ravoxertinib,ERK 抑制剂
|
R174276-50mg
|
Moligand™, ≥97% |
1453848-26-4 |
50mg
|
¥ 6699.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Ravoxertinib,ERK 抑制剂
|
R174276-2mg
|
Moligand™, ≥97% |
1453848-26-4 |
2mg
|
¥ 484.9
|
现货 |
|
0 |
阿拉丁 |
|
Ravoxertinib,ERK 抑制剂
|
R174276-25mg
|
Moligand™, ≥97% |
1453848-26-4 |
25mg
|
¥ 3799.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Ravoxertinib,ERK 抑制剂
|
R174276-10mg
|
Moligand™, ≥97% |
1453848-26-4 |
10mg
|
¥ 2199.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-1-乙酰-3-吡咯烷醇
|
R160915-250mg
|
≥98% |
916733-17-0 |
250mg
|
¥ 179.9
|
现货 |
|
0 |
阿拉丁 |
|
(1R,3S)-3-(苄氧羰基氨基)环己甲酸
|
R160875-25mg
|
≥98% |
1259278-10-8 |
25mg
|
¥ 399.9
|
现货 |
|
0 |
阿拉丁 |
|
(1R,2S)-N1-(叔丁氧羰基)-1,2-环己烷二胺
|
R160856-250mg
|
≥98% |
364385-54-6 |
250mg
|
¥ 94.9
|
现货 |
|
0 |
阿拉丁 |
|
(1R,3S)-3-(叔丁氧羰基氨基)环己甲酸
|
R160830-250mg
|
≥97% |
222530-39-4 |
250mg
|
¥ 319.9
|
现货 |
|
0 |
阿拉丁 |
|
(1R,3S)-3-(叔丁氧羰基氨基)环己甲酸
|
R160830-100mg
|
≥97% |
222530-39-4 |
100mg
|
¥ 159.9
|
现货 |
|
0 |
阿拉丁 |
|
DL-去甲变肾上腺素盐酸盐
|
R132741-5mg
|
≥95% |
1011-74-1 |
5mg
|
¥ 448.9
|
现货 |
|
0 |
阿拉丁 |
|
DL-去甲变肾上腺素盐酸盐
|
R132741-25mg
|
≥95% |
1011-74-1 |
25mg
|
¥ 1168.9
|
现货 |
|
0 |
阿拉丁 |
|
DL-去甲变肾上腺素盐酸盐
|
R132741-10mg
|
≥95% |
1011-74-1 |
10mg
|
¥ 718.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-1-BOC-3-氨甲基吡咯烷
|
R132705-100mg
|
≥95%(HPLC) |
199174-29-3 |
100mg
|
¥ 129.9
|
现货 |
|
0 |
阿拉丁 |
|
QPhos Pd G3
|
Q486844-250mg
|
|
2021255-91-2 |
250mg
|
¥ 779.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
季铵盐
|
Q486819-25mg
|
|
188-73-8 |
25mg
|
¥ 2432.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-喹啉甲醛
|
Q482895-250mg
|
试剂级 |
N/A |
250mg
|
¥ 668.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-(2-喹啉基)-1-[4-(三氟甲基)苯基]乙酮
|
Q482862-100mg
|
试剂级 |
N/A |
100mg
|
¥ 412.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
8-喹啉乙酸
|
Q482776-50mg
|
试剂级 |
N/A |
50mg
|
¥ 668.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-喹啉基甲胺
|
Q482757-10mg
|
试剂级 |
N/A |
10mg
|
¥ 456.9
|
期货,请咨询 |
|
0 |
阿拉丁 |